Skin Analytics, a UK health technology company specialising in AI-powered skin cancer detection, has joined the Association of Medical Insurers and Intermediaries (AMII) as a corporate member.
Founded in 2012 by Neil Daly, Skin Analytics works with healthcare partners to build skin cancer pathways.
Trusted within the NHS since 2020 and supporting private healthcare partners since 2015, the company focuses on improving early diagnosis, patient access and clinical efficiency through evidence-based technology.
Dan Mullarkey, medical director at Skin Analytics (pictured), said: “Joining AMII gives us the opportunity to collaborate more closely with insurers and intermediaries, supporting the continued development of efficient, high-quality dermatology pathways across the market.”
Dave Middleton, executive chairman of AMII, said: “We are delighted to welcome Skin Analytics as a corporate member of AMII. Their work showcases the role technology can play in improving early diagnosis, pathway efficiency and patient outcomes.”
